Display options
Cite
Nicolini G, Pitto L, Kusmic C, et al. New insights into mechanisms of cardioprotection mediated by thyroid hormones. J Thyroid Res. 2013;2013:264387doi: 10.1155/2013/264387.
Nicolini, G., Pitto, L., Kusmic, C., Balzan, S., Sabatino, L., Iervasi, G., & Forini, F. (2013). New insights into mechanisms of cardioprotection mediated by thyroid hormones. Journal of thyroid research, 2013264387. https://doi.org/10.1155/2013/264387
Nicolini, G, et al. "New insights into mechanisms of cardioprotection mediated by thyroid hormones." Journal of thyroid research vol. 2013 (2013): 264387. doi: https://doi.org/10.1155/2013/264387
Nicolini G, Pitto L, Kusmic C, Balzan S, Sabatino L, Iervasi G, Forini F. New insights into mechanisms of cardioprotection mediated by thyroid hormones. J Thyroid Res. 2013;2013:264387. doi: 10.1155/2013/264387. Epub 2013 Mar 10. PMID: 23555069; PMCID: PMC3608184.
Copy Download .nbib Format: NLM
Share it on

J Thyroid Res. 2013;2013:264387. doi: 10.1155/2013/264387. Epub 2013 Mar 10.

New insights into mechanisms of cardioprotection mediated by thyroid hormones.

Journal of thyroid research

G Nicolini, L Pitto, C Kusmic, S Balzan, L Sabatino, G Iervasi, F Forini

Affiliations

  1. Institute of Clinical Physiology, CNR, 56100 Pisa, Italy ; CNR, Tuscany Region G. Monasterio Foundation, Pisa, Italy.

PMID: 23555069 PMCID: PMC3608184 DOI: 10.1155/2013/264387

Abstract

Heart failure represents the final common outcome in cardiovascular diseases. Despite significant therapeutic advances, morbidity and mortality of heart failure remain unacceptably high. Heart failure is preceded and sustained by a process of structural remodeling of the entire cardiac tissue architecture. Prevention or limitation of cardiac remodeling in the early stages of the process is a crucial step in order to ameliorate patient prognosis. Acquisition of novel pathophysiological mechanisms of cardiac remodeling is therefore required to develop more efficacious therapeutic strategies. Among all neuroendocrine systems, thyroid hormone seems to play a major homeostatic role in cardiovascular system. In these years, accumulating evidence shows that the "low triiodothyronine" syndrome is a strong prognostic, independent predictor of death in patients affected by both acute and chronic heart disease. In experimental models of cardiac hypertrophy or myocardial infarction, alterations in the thyroid hormone signaling, concerning cardiac mitochondrion, cardiac interstitium, and vasculature, have been suggested to be related to heart dysfunction. The aim of this brief paper is to highlight new developments in understanding the cardioprotective role of thyroid hormone in reverting regulatory networks involved in adverse cardiac remodeling. Furthermore, new recent advances on the role of specific miRNAs in thyroid hormone regulation at mitochondrion and interstitial level are also discussed.

References

  1. Circulation. 2007 Oct 9;116(15):1725-35 - PubMed
  2. Thyroid Res. 2011 Aug 03;4 Suppl 1:S6 - PubMed
  3. J Clin Invest. 2005 Mar;115(3):565-71 - PubMed
  4. J Clin Invest. 2010 Jan;120(1):254-65 - PubMed
  5. Vascul Pharmacol. 2010 Mar-Apr;52(3-4):131-7 - PubMed
  6. Basic Res Cardiol. 2009 Jan;104(1):69-77 - PubMed
  7. Am J Physiol Heart Circ Physiol. 2000 Jul;279(1):H422-8 - PubMed
  8. Dev Cell. 2009 Nov;17(5):662-73 - PubMed
  9. Physiol Rev. 1999 Jan;79(1):215-62 - PubMed
  10. Mol Cell Biochem. 2003 May;247(1-2):61-8 - PubMed
  11. Nat Med. 2011 Jan;17(1):71-8 - PubMed
  12. PLoS One. 2011;6(9):e25054 - PubMed
  13. Heart Fail Rev. 2008 Jun;13(2):137-50 - PubMed
  14. Annu Rev Pharmacol Toxicol. 2005;45:657-87 - PubMed
  15. Circ Res. 1994 Aug;75(2):245-51 - PubMed
  16. J Mol Cell Cardiol. 2003 Dec;35(12):1385-94 - PubMed
  17. Circ Res. 2004 Jun 11;94(11):1500-6 - PubMed
  18. PLoS Genet. 2010 Jan;6(1):e1000795 - PubMed
  19. Am J Med. 1990 Jun;88(6):626-30 - PubMed
  20. J Hypertens. 2004 Jan;22(1):47-50 - PubMed
  21. N Engl J Med. 1990 May 31;322(22):1561-6 - PubMed
  22. Thyroid. 2002 Jun;12(6):447-52 - PubMed
  23. N Engl J Med. 2001 Feb 15;344(7):501-9 - PubMed
  24. Intern Med. 2012;51(21):3009-15 - PubMed
  25. Am J Physiol Cell Physiol. 2012 May 1;302(9):C1346-52 - PubMed
  26. Nat Rev Mol Cell Biol. 2013 Jan;14(1):38-48 - PubMed
  27. Biochem Biophys Res Commun. 1993 Apr 15;192(1):151-60 - PubMed
  28. Circulation. 2008 Jul 8;118(2):166-75 - PubMed
  29. J Clin Invest. 2007 Sep;117(9):2431-44 - PubMed
  30. J Card Fail. 2006 Sep;12(7):520-6 - PubMed
  31. J Clin Invest. 2000 Oct;106(7):857-66 - PubMed
  32. Cardiovasc Res. 2006 Feb 15;69(3):646-56 - PubMed
  33. J Mol Cell Cardiol. 2005 Aug;39(2):319-26 - PubMed
  34. N Engl J Med. 1995 Dec 7;333(23):1562-3 - PubMed
  35. Ann N Y Acad Sci. 2006 Oct;1080:165-77 - PubMed
  36. J Clin Endocrinol Metab. 2000 Sep;85(9):2993-3001 - PubMed
  37. J Cell Biochem. 2012 Apr;113(4):1104-10 - PubMed
  38. J Clin Invest. 1997 Oct 15;100(8):1991-9 - PubMed
  39. Cardiovasc Pathol. 2005 May-Jun;14(3):135-44 - PubMed
  40. Vascul Pharmacol. 2010 Mar-Apr;52(3-4):146-50 - PubMed
  41. Am J Physiol Heart Circ Physiol. 2001 Oct;281(4):H1690-6 - PubMed
  42. Thyroid. 2002 Jun;12(6):453-7 - PubMed
  43. Heart Fail Rev. 2011 Jan;16(1):79-96 - PubMed
  44. J Mol Endocrinol. 2001 Feb;26(1):67-77 - PubMed
  45. Circulation. 2010 Jul 27;122(4):385-93 - PubMed
  46. Circ Res. 2002 Mar 22;90(5):520-30 - PubMed
  47. J Cell Mol Med. 2011 Mar;15(3):514-24 - PubMed
  48. Can J Physiol Pharmacol. 2012 Aug;90(8):977-87 - PubMed
  49. Cardiovasc Res. 2005 Jan 1;65(1):40-51 - PubMed
  50. J Mol Cell Cardiol. 2008 Jan;44(1):180-7 - PubMed
  51. J Mol Cell Cardiol. 2005 Nov;39(5):841-4 - PubMed
  52. Cardiovasc Drugs Ther. 2011 Apr;25(2):171-82 - PubMed
  53. Science. 2007 Apr 27;316(5824):575-9 - PubMed
  54. Circ Res. 2003 Aug 22;93(4):292-301 - PubMed
  55. Annu Rev Physiol. 2010;72:61-80 - PubMed
  56. Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1931-6 - PubMed
  57. Mol Endocrinol. 2005 Dec;19(12):2955-63 - PubMed
  58. Vascul Pharmacol. 2010 Mar-Apr;52(3-4):142-5 - PubMed
  59. Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1780-5 - PubMed
  60. Am J Physiol Heart Circ Physiol. 2001 Jun;280(6):H2726-31 - PubMed
  61. J Clin Endocrinol Metab. 2007 May;92(5):1715-23 - PubMed
  62. Endocrinology. 2002 Jul;143(7):2812-5 - PubMed
  63. Heart Fail Rev. 2010 Mar;15(2):125-32 - PubMed
  64. Circ Res. 1990 Oct;67(4):787-94 - PubMed
  65. Microcirculation. 2003 Apr;10(2):113-26 - PubMed
  66. J Cell Mol Med. 2012 Nov;16(11):2726-35 - PubMed
  67. J Clin Invest. 2009 Sep;119(9):2772-86 - PubMed
  68. Heart Fail Rev. 2010 Mar;15(2):155-69 - PubMed
  69. Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13027-32 - PubMed
  70. Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2049-55 - PubMed
  71. Physiol Rev. 2007 Oct;87(4):1285-342 - PubMed
  72. J Mol Cell Cardiol. 2002 Oct;34(10):1273-8 - PubMed
  73. Mol Cell Endocrinol. 2000 Apr 25;162(1-2):45-55 - PubMed
  74. Curr Opin Cardiol. 2005 May;20(3):211-6 - PubMed
  75. Arch Intern Med. 2002 Jun 24;162(12):1388-94 - PubMed
  76. Matrix Biol. 2007 May;26(4):269-79 - PubMed
  77. Am J Physiol. 1998 Jul;275(1):H264-73 - PubMed
  78. Circulation. 2003 Feb 11;107(5):708-13 - PubMed
  79. Mol Cell Biochem. 2004 Oct;265(1-2):97-106 - PubMed
  80. Pharmacol Ther. 2008 May;118(2):277-94 - PubMed
  81. Endocr Rev. 2005 Aug;26(5):704-28 - PubMed
  82. Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1506-11 - PubMed
  83. J Mol Cell Cardiol. 1998 Nov;30(11):2495-506 - PubMed
  84. Nat Med. 2002 Jul;8(7):725-30 - PubMed
  85. Circ Res. 1992 Oct;71(4):831-9 - PubMed
  86. Curr Cardiol Rev. 2009 Jan;5(1):12-6 - PubMed
  87. Cardiovasc Res. 2001 Aug 1;51(2):322-30 - PubMed
  88. Endocrinology. 2005 Jul;146(7):2864-71 - PubMed
  89. Am Heart J. 2001 Mar;141(3):334-41 - PubMed

Publication Types